A cross-species study has identified key genes that govern regeneration, revealing a potential path toward inducing limb ...
Women’s football in Moray can develop even further thanks to the creation of a pathway partnership. Elgin City women’s team, ...
C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...
Targeted modulation of certain intracellular signaling proteins could represent an exciting new approach to drug development. In a recently published review, a research team led by MedUni Vienna ...
Multi-omics profiling of residual cancer burden after neoadjuvant hormonal therapy guides subtype-directed treatment in high-risk and locally advanced prostate cancer. Predictive associations between ...
The FDA’s Breakthrough Devices Program is designed to accelerate development and review of devices that offer meaningful advances in care for serious or life-threatening conditions. With more than ...
INDIANAPOLIS – In a unanimous vote, the Indiana House of Representatives passed House Bill 1277, a piece of legislation aimed at overhauling the state’s embattled PathWays for Aging Medicaid program.
Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may outperform existing treatments from Apellis Pharmaceuticals and Astellas ...
SCRANTON, Pa. — Sergio Chavez Jiminez, a resident and business owner in Danville, was detained by ICE over the weekend. Federals officials tell Newswatch16, Jiminez was detained due an unlawful status ...
UCSF is preparing to accept its latest batch of trainees as part of a $14 million workforce-development initiative for young San Francisco adults. Michael Jones, the program director at Career ...
The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results